ZA200906328B - Intravesical apaziquone administration following transurethral resection for treating cancer - Google Patents

Intravesical apaziquone administration following transurethral resection for treating cancer

Info

Publication number
ZA200906328B
ZA200906328B ZA200906328A ZA200906328A ZA200906328B ZA 200906328 B ZA200906328 B ZA 200906328B ZA 200906328 A ZA200906328 A ZA 200906328A ZA 200906328 A ZA200906328 A ZA 200906328A ZA 200906328 B ZA200906328 B ZA 200906328B
Authority
ZA
South Africa
Prior art keywords
apaziquone
intravesical
treating cancer
transurethral resection
administration following
Prior art date
Application number
ZA200906328A
Other languages
English (en)
Inventor
Luigi Lenaz
Shanta Chawla
Mario Beer
Original Assignee
Spectrum Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrum Pharmaceuticals Inc filed Critical Spectrum Pharmaceuticals Inc
Publication of ZA200906328B publication Critical patent/ZA200906328B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200906328A 2007-03-13 2009-09-11 Intravesical apaziquone administration following transurethral resection for treating cancer ZA200906328B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89461007P 2007-03-13 2007-03-13

Publications (1)

Publication Number Publication Date
ZA200906328B true ZA200906328B (en) 2010-05-26

Family

ID=39494173

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200906328A ZA200906328B (en) 2007-03-13 2009-09-11 Intravesical apaziquone administration following transurethral resection for treating cancer

Country Status (17)

Country Link
US (1) US20080227841A1 (ja)
EP (1) EP2134322B1 (ja)
JP (2) JP5788143B2 (ja)
KR (1) KR20090128479A (ja)
CN (1) CN101677942B (ja)
AR (1) AR065732A1 (ja)
AU (1) AU2008224962B2 (ja)
BR (1) BRPI0808804A2 (ja)
CA (1) CA2680481C (ja)
ES (1) ES2727257T3 (ja)
IL (1) IL200899A0 (ja)
MX (1) MX2009009777A (ja)
NZ (1) NZ579609A (ja)
RU (2) RU2480200C2 (ja)
TW (1) TWI434684B (ja)
WO (1) WO2008112934A1 (ja)
ZA (1) ZA200906328B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201213486D0 (en) * 2012-07-30 2012-09-12 Univ Salford The Quinone compounds and their uses for the treatment of cancer
WO2014062856A1 (en) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2178305C1 (ru) * 2000-11-02 2002-01-20 Гарбер Александр Григорьевич Ирригационный раствор
US6894071B2 (en) * 2001-11-01 2005-05-17 Spectrum Pharmaceuticals, Inc. Medical compositions for intravesical treatment of bladder cancer
RU2002121829A (ru) * 2002-08-07 2004-02-27 Сгму Способ лечения местнораспространенных форм рака мочевого пузыря

Also Published As

Publication number Publication date
CA2680481A1 (en) 2008-09-18
RU2623142C2 (ru) 2017-06-22
TWI434684B (zh) 2014-04-21
AU2008224962A1 (en) 2008-09-18
CN101677942B (zh) 2013-10-30
KR20090128479A (ko) 2009-12-15
JP5788143B2 (ja) 2015-09-30
TW200904410A (en) 2009-02-01
AR065732A1 (es) 2009-06-24
EP2134322A1 (en) 2009-12-23
CN101677942A (zh) 2010-03-24
MX2009009777A (es) 2009-11-26
NZ579609A (en) 2012-01-12
US20080227841A1 (en) 2008-09-18
AU2008224962B2 (en) 2013-07-25
EP2134322B1 (en) 2019-02-20
WO2008112934A1 (en) 2008-09-18
BRPI0808804A2 (pt) 2014-08-19
RU2009137770A (ru) 2011-04-20
RU2480200C2 (ru) 2013-04-27
JP2014028841A (ja) 2014-02-13
ES2727257T3 (es) 2019-10-15
CA2680481C (en) 2016-06-21
JP2010521488A (ja) 2010-06-24
RU2012157329A (ru) 2014-07-10
IL200899A0 (en) 2010-05-17

Similar Documents

Publication Publication Date Title
EP2152722A4 (en) COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER
PL2358697T3 (pl) Związki izoindolinowe do zastosowania w leczeniu raka
ZA201004403B (en) Therapeutic cancer treatments
HK1137158A1 (en) Formulations for cancer treatment
HK1131577A1 (en) Compositions for treating cancer
ZA200807934B (en) Cancer treatments
EP2127671A4 (en) THERAPEUTIC AGENT AGAINST CANCER
EP1996182A4 (en) CANCER TREATMENT WITH GAMMA SECRETASE INHIBITORS
EP1990418A4 (en) ONCOLYTIC ADENOVIRUS FOR THE TREATMENT OF CANCER
PL2559439T3 (pl) Preparat farmaceutyczny do leczenia łagodnego rozrostu gruczołu krokowego
IL206563A0 (en) Medicament for the treatment of cancer of the pancreas
EP2144888A4 (en) METHODS OF TREATING CANCER
EP2068911A4 (en) METHOD FOR THE TREATMENT OF CANCER
IL200899A0 (en) Intravesical apaziquone administration following transurethral resection for treating cancer
GB0707556D0 (en) Treatment for cancer
EP2099303A4 (en) THERAPEUTIC COMPOSITIONS ON TETRAHYDROISOCHINOLINE BASE FOR CANCER THERAPY
GB0611130D0 (en) Cancer treatment
GB0619271D0 (en) Treating cancer
GB0604741D0 (en) Cancer Treatment
GB0618199D0 (en) Cancer treatment
AU2007906570A0 (en) Compounds for treating cancer
GB0612259D0 (en) Cancer therapeutic
GB0606702D0 (en) Cancer therapeutic
GB0723503D0 (en) Cancer treatment
GB0700493D0 (en) Cancer treatment